Subgroup analysis showed that age ≤ 19 years was a significant negative prognostic factor for tumor control in NF2‐VS patients (p < 0.001), whereas no such correlation was found in the S‐VS cohort (p = 0.78). The gene discussed is NF2; the disease is neoplasm.